Synthesis and in vitro carbonic anhydrase and acetylcholinesterase inhibitory activities of novel hydrazide–hydrazone compounds containing 1,2,4-triazole ring

References

• Ökten, S.; Ekiz, M.; Koçyiğit, Ü. M.; Tutar, A.; Çelik, İ.; Akkurt, M.; Gökalp, F.; Taslimi, P.; Gülçin, İ. Synthesis, Characterization, Crystal Structures, Theoretical Calculations and Biological Evaluations of Novel Substituted Tacrine Derivatives as Cholinesterase and Carbonic Anhydrase Enzymes İnhibitors. J. Mol. Struct. 2019, 1175, 906–915. DOI: 10.1016/j.molstruc.2018.08.063.
   Web of Science ®Google Scholar
• Occhipinti, R.; Boron, W. F. Role of Carbonic Anhydrases and İnhibitors in Acid–Base Physiology: İnsights from Mathematical Modeling. Int. J. Mol. Sci. 2019, 20, 3841. DOI: 10.3390/ijms20153841.
   PubMed Web of Science ®Google Scholar
• Supuran, C. T.; Scozzafava, A.; Mincione, F. The Development of Topically Acting Carbonic Anhydrase İnhibitors as Antiglaucoma Agents. Curr. Pharm. Des. 2008, 14, 649–654. DOI: 10.2174/138161208783877866.
   PubMed Web of Science ®Google Scholar
• Gul, H. I.; Yamali, C.; Bulbuller, M.; Kirmizibayrak, P. B.; Gul, M.; Angeli, A.; Bua, S.; Supuran, C. T. Anticancer Effects of New Dibenzenesulfonamides by İnducing Apoptosis and Autophagy Pathways and Their Carbonic Anhydrase İnhibitory Effects on hCA I, hCA II, hCA IX, hCA XII İsoenzymes. Bioorg. Chem. 2018, 78, 290–297. DOI: 10.1016/j.bioorg.2018.03.027.
   PubMed Web of Science ®Google Scholar
• Supuran, C. T.; Scozzafava, A. Carbonic Anhydrases as Targets for Medicinal Chemistry. Bioorg. Med. Chem. 2007, 15, 4336–4350. DOI: 10.1016/j.bmc.2007.04.020.
   PubMed Web of Science ®Google Scholar
• Ciccone, L.; Cerri, C.; Nencetti, S.; Orlandini, E. Carbonic Anhydrase İnhibitors and Epilepsy: State of the Art and Future Perspectives. Molecules 2012, 26, 6380. DOI: 10.3390/molecules26216380.
   Google Scholar
• Capasso, C.; Supuran, C. T. Bacterial, Fungal and Protozoan Carbonic Anhydrases as Drug Targets. Expert Opin. Ther. Targets. 2015, 19, 1689–1704. DOI: 10.1517/14728222.2015.1067685.
   PubMed Web of Science ®Google Scholar
• Lomelino, C. L.; Supuran, C. T.; McKenna, R. Non-Classical İnhibition of Carbonic Anhydrase. Int. J. Mol. Sci. 2016, 17, 1150. DOI: 10.3390/ijms17071150.
   PubMed Web of Science ®Google Scholar
• Saadiq, Muhammad, Uddin, Ghias, Latif, Abdul, Ali, Mumtaz, Akbar, Nazia, Ali, Sardar, Ahmad, Manzoor, Zahoor, Mohammad, Khan, Ajmal, Al-Harrasi, Ahmed, Ammara. Synthesis, Bioactivity Assessment, and Molecular Docking of Non-Sulfonamide Benzimidazole-Derived N-Acylhydrazone Scaffolds as Carbonic Anhydrase-II İnhibitors. ACS Omega 2022, 7, 705–715. DOI: 10.1021/acsomega.1c05362.
   PubMed Web of Science ®Google Scholar
• Zhou, L-y.; Zhu, Y.; Jiang, Y-r.; Zhao, X-j.; Guo, D. Design, Synthesis and Biological Evaluation of Dual Acetylcholinesterase and Phosphodiesterase 5A İnhibitors in Treatment for Alzheimer’s Disease. Bioorg. Med. Chem. Lett. 2017, 27, 4180–4184. DOI: 10.1016/j.bmcl.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Norton, S.; Matthews, F. E.; Barnes, D. E.; Yaffe, K.; Brayne, C. Potential for Primary Prevention of Alzheimer’s Disease: An Analysis of Population-Based Data. Lancet. Neurol. 2014, 13, 788–794. DOI: 10.1016/j.ejmech.2014.02.026.
   PubMed Web of Science ®Google Scholar
• Kumar, S.; Chowdhury, S.; Kumar, S. In Silico Repurposing of Antipsychotic Drugs for Alzheimer’s Disease. BMC Neurosci. 2017, 18, 76. DOI: 10.1186/s12868-017-0394-8.
   PubMed Web of Science ®Google Scholar
• Craig, L. A.; Hong, N. S.; McDonald, R. J. Revisiting the Cholinergic Hypothesis in the Development of Alzheimer’s Disease. Neurosci. Biobehav. Rev. 2011, 35, 1397–1409. DOI: 10.1016/j.neubiorev.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Inestrosa, N. C.; Sagal, J. P.; Colombres, M. Acetylcholinesterase İnteraction with Alzheimer Amyloid β. In Alzheimer’s Disease: Cellular and Molecular Aspects of Amyloid β; Harris, R.; Fahrenholz, F., Eds.; Springer: Berlın, 2005, 299–317.
   Google Scholar
• Provensi, G.; Carta, F.; Nocentini, A.; Supuran, C. T.; Casamenti, F.; Passani, M. B.; Fossati, S. A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer’s Disease. Int. J. Mol. Sci. 2019, 20, 4724. DOI: 10.3390/ijms20194724.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Figueroa, B. E.; Stavrovskaya, I. G.; Zhang, Y.; Sirianni, A. C.; Zhu, S.; Day, A. L.; Kristal, B. S.; Friedlander, R. M. Methazolamide and Melatonin İnhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of İschemic İnjury. Stroke 2009, 40, 1877–1885. DOI: 10.1161/STROKEAHA.108.540765.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Zhu, S.; Pei, Z.; Drozda, M.; Stavrovskaya, I. G.; Del Signore, S. J.; Cormier, K.; Shimony, E. M.; Wang, H.; Ferrante, R. J.; et al. Inhibitors of Cytochrome C Release with Therapeutic Potential for Huntington’s Disease. J. Neurosci. 2008, 28, 9473–9485. DOI: 10.1523/JNEUROSCI.1867-08.2008.
   PubMed Web of Science ®Google Scholar
• Jang, B. G.; Yun, S.-M.; Ahn, K.; Song, J. H.; Jo, S. A.; Kim, Y.-Y.; Kim, D. K.; Park, M. H.; Han, C.; Koh, Y. H. Plasma Carbonic Anhydrase II Protein is Elevated in Alzheimer’s Disease. J. Alzheimers. Dis. 2010, 21, 939–945. DOI: 10.3233/JAD-2010-100384.
   PubMed Web of Science ®Google Scholar
• Sultana, R.; Boyd-Kimball, D.; Cai, J.; Pierce, W. M.; Klein, J. B.; Merchant, M.; Butterfield, D. A. Proteomics Analysis of the Alzheimer’s Disease Hippocampal Proteome. J. Alzheimers. Dis. 2007, 11, 153–164. DOI: 10.3233/JAD-2007-11203.
   PubMed Web of Science ®Google Scholar
• Dehestani, L.; Ahangar, N.; Hashemi, S. M.; Irannejad, H.; Masihi, P. H.; Shakiba, A.; Emami, S. Design, Synthesis, in Vivo and in Silico Evaluation of Phenacyl Triazole Hydrazones as New Anticonvulsant Agents. Bioorg. Chem. 2018, 78, 119–129. DOI: 10.1016/j.bioorg.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Kumar, D.; Kumar, N. M.; Ghosh, S.; Shah, K. Novel Bis (İndolyl) Hydrazide–Hydrazones as Potent Cytotoxic Agents. Bioorg. Med. Chem. Lett. 2012, 22, 212–215. DOI: 10.1016/j.bmcl.2011.11.031.
   PubMed Web of Science ®Google Scholar
• Nasr, T.; Bondock, S.; Youns, M. Anticancer Activity of New Coumarin Substituted Hydrazide–Hydrazone Derivatives. Eur. J. Med. Chem. 2014, 76, 539–548. DOI: 10.1016/j.ejmech.2014.02.026.
   PubMed Web of Science ®Google Scholar
• Salgin-Gökşen, U.; Gökhan-Kelekçi, N.; Göktaş, O.; Köysal, Y.; Kiliç, E.; Işik, S.; Aktay, G.; Ozalp, M. 1-Acylthiosemicarbazides, 1,2,4-Triazole-5(4H)-Thiones, 1,3,4-Thiadiazoles and Hydrazones Containing 5-Methyl-2-Benzoxazolinones: Synthesis, Analgesic-Anti-İnflammatory and Antimicrobial Activities. Bioorg. Med. Chem. 2007, 15, 5738–5751. DOI: 10.1016/j.bmc.2007.06.006.
   PubMed Web of Science ®Google Scholar
• Şenkardeş, S.; Kaushik-Basu, N.; Durmaz, I.; Manvar, D.; Basu, A.; Atalay, R.; Küçükgüzel, ŞG. Synthesis of Novel Diflunisal Hydrazide–Hydrazones as Anti-Hepatitis C Virus Agents and Hepatocellular Carcinoma İnhibitors. Eur. J. Med. Chem. 2016, 108, 301–308. DOI: 10.1016/j.ejmech.2015.10.041.
   PubMed Web of Science ®Google Scholar
• Settypalli, T.; Chunduri, V. R.; Maddineni, A. K.; Begari, N.; Allagadda, R.; Kotha, P.; Chippada, A. R. Design, Synthesis, in Silico Docking Studies and Biological Evaluation of Novel Quinoxaline-Hydrazide Hydrazone-1,2,3-Triazole Hybrids as α-Glucosidase İnhibitors and Antioxidants. New J. Chem. 2019, 43, 15435–15452. DOI: 10.1039/C9NJ02580D.
   Web of Science ®Google Scholar
• Taha, M.; Ismail, N. H.; Baharudin, M. S.; Lalani, S.; Mehboob, S.; Khan, K. M.; Yousuf, S.; Siddiqui, S.; Rahim, F.; Choudhary, M. I. Synthesis Crystal Structure of 2-Methoxybenzoylhydrazones and Evaluation of Their α-Glucosidase and Urease İnhibition Potential. Med. Chem. Res. 2015, 24, 1310–1324. DOI: 10.1007/s00044-014-1213-8.
   Web of Science ®Google Scholar
• Upegui, Y.; Rios, K.; Quiñones, W.; Echeverri, F.; Archbold, R.; Murillo, J. D.; Torres, F.; Escobar, G.; Vélez, I. D.; Robledo, S. M. Chroman-4-One Hydrazones Derivatives: Synthesis, Characterization, and in Vitro and in Vivo Antileishmanial Effects. Med. Chem. Res. 2019, 28, 2184–2199. DOI: 10.1007/s00044-019-02446-x.
   Web of Science ®Google Scholar
• Dincel, E. D.; Akdağ, Ç.; Kayra, T.; Coşar, E. D.; Aksoy, M. O.; Akalın-Çiftçi, G.; Ulusoy-Güzeldemirci, N. Design, Synthesis, Characterization, Molecular Docking Studies and Anticancer Activity Evaluation of Novel Hydrazinecarbothioamide, 1,2,4-Triazole-3-Thione, 4-Thiazolidinone and 1,3,4-Oxadiazole Derivatives. J. Mol. Struct. 2022, 1268, 133710. DOI: 10.1016/j.molstruc.2022.133710.
   Web of Science ®Google Scholar
• Dincel, E. D.; Hasbal-Celikok, G.; Yilmaz-Ozden, T.; Ulusoy-Güzeldemirci, N. Design, Biological Evaluation, Molecular Docking Study and in Silico ADME Prediction of Novel İmidazo [2,1-b] Thiazole Derivatives as a Novel Class of α-Glucosidase İnhibitors. J. Mol. Struct. 2021, 1245, 131260. DOI: 10.1016/j.molstruc.2021.131260.
   Web of Science ®Google Scholar
• Dincel, E. D.; Ulusoy‐Güzeldemirci, N.; Şatana, D.; Küçükbasmacı, Ö. Design, Synthesis, Characterization and Antimicrobial Evaluation of Some Novel Hydrazinecarbothioamide, 4‐Thiazolidinone and 1,2,4‐Triazole‐3‐Thione Derivatives. J. Heterocycl. Chem. 2021, 58, 195–205. DOI: 10.1002/jhet.4159.
   Web of Science ®Google Scholar
• Güzeldemirci, N. U.; Küçükbasmaci, O. Synthesis and Antimicrobial Activity Evaluation of New 1,2,4-Triazoles and 1,3,4-Thiadiazoles Bearing İmidazo[2,1-b]Thiazole Moiety. Eur. J. Med. Chem. 2010, 45, 63–68. DOI: 10.1016/j.ejmech.2009.09.024.
   PubMed Web of Science ®Google Scholar
• Ulusoy, N.; Gürsoy, A.; Otük, G. Synthesis and Antimicrobial Activity of Some 1,2,4-Triazole-3-Mercaptoacetic Acid Derivatives. Farmaco 2001, 56, 947–952. DOI: 10.1016/S0014-827X(01)01128-4.
   PubMedGoogle Scholar
• Koparir, M.; Orek, C.; Parlak, A. E.; Söylemez, A.; Koparir, P.; Karatepe, M.; Dastan, S. D. Synthesis and Biological Activities of Some Novel Aminomethyl Derivatives of 4-Substituted-5-(2-Thienyl)-2,4-Dihydro-3H-1,2,4-Triazole-3-Thiones. Eur. J. Med. Chem. 2013, 63, 340–346. DOI: 10.1016/j.ejmech.2013.02.025.
   PubMed Web of Science ®Google Scholar
• Verpoorte, J. A.; Mehta, S.; Edsall, J. T. Esterase Activities of Human Carbonic Anhydrases B and C. J. Biol. Chem. 1967, 242, 4221–4229. DOI: 10.1016/S0021-9258(18)95800-X.
   PubMed Web of Science ®Google Scholar
• Tugrak, M.; Gul, H. I.; Sakagami, H.; Gulcin, I.; Supuran, C. T. New Azafluorenones with Cytotoxic and Carbonic Anhydrase İnhibitory Properties: 2-Aryl-4-(4-Hydroxyphenyl)-5H-İndeno[1,2-b]Pyridin-5-Ones. Bioorg. Chem. 2018, 81, 433–439. DOI: 10.1016/j.bioorg.2018.09.013.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254. DOI: 10.1016/0003-2697(76)90527-3.
   PubMed Web of Science ®Google Scholar
• Ellman, G. L.; Courtney, K. D.; Andres, V.; Feather-Stone, R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961, 7, 88–95. DOI: 10.1016/0006-2952(61)90145-9.
   PubMed Web of Science ®Google Scholar
• Ozgun, D. O.; Yamali, C.; Gul, H. I.; Taslimi, P.; Gulcin, I.; Yanik, T.; Supuran, C. T. Inhibitory Effects of İsatin Mannich Bases on Carbonic Anhydrases, Acetylcholinesterase, and Butyrylcholinesterase. J. Enzyme Inhib. Med. Chem. 2016, 31, 1498–1501. DOI: 10.3109/14756366.2016.1149479.
   PubMed Web of Science ®Google Scholar